Expression of ERp5 and GRP78 on the membrane of chronic lymphocytic leukemia cells: association with soluble MICA shedding.
MICA is a ligand of the activating receptor NKG2D, expressed by NK and T cells. MICA expression is induced in cancer cells favoring their elimination by the immune system; however, many advanced tumors shed soluble MICA (sMICA), which impairs NKG2D-mediated cytotoxicity. ERp5 and GRP78 are endoplasmic reticulum-resident proteins that are translocated to the surface of epithelial tumor cells where they interact with MICA and are involved in sMICA shedding. In this study, we analyze the role of ERp5 and GRP78 in sMICA shedding in chronic lymphocytic leukemia (CLL). Immunofluorescence and flow cytometry analyses showed that ERp5 and GRP78 were significantly expressed on the surface of B cells and leukemia cells, but they were not expressed on T cells. The expression of ERp5 and GRP78 was significantly higher in leukemia cells than in B cells from controls. ERp5 and GRP78 co-localized with MICA on the surface of leukemia cells and the levels of expression of ERp5 and GRP78 correlated with the level of expression of membrane-bound MICA in CLL patients. Associated with higher expression of membrane-bound ERp5 and GRP78, serum sMICA levels were approximately threefold higher in patients than in controls. Elevated sMICA levels in CLL patients were associated with the down-modulation of NKG2D surface expression on CD8 T cells. Finally, pharmacological inhibition of B cell lines and stimulated leukemia cells showed that ERp5 activity is involved in sMICA shedding in CLL. In conclusion, these results uncover a molecular mechanism which regulates MICA protein shedding and immune evasion in CLL.
Functional Biology Department. Instituto Universitario Oncologico del Principado de Asturias (IUOPA), Universidad de Oviedo, Oviedo, Spain.
Leticia
L
Huergo-Zapico
Ana P
AP
Gonzalez-Rodriguez
Juan
J
Contesti
Esther
E
Gonzalez
Alejandro
A
López-Soto
Azahara
A
Fernandez-Guizan
Andrea
A
Acebes-Huerta
Juan R
JR
de Los Toyos
Carlos
C
Lopez-Larrea
Veronika
V
Groh
Thomas
T
Spies
Segundo
S
Gonzalez
D000368:Aged; D000091342:Endoplasmic Reticulum Chaperone BiP; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005434:Flow Cytometry; D005455:Fluorescent Antibody Technique; D015395:Histocompatibility Antigens Class I / Q000378:metabolism*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000276:immunology / Q000378:metabolism*; D008297:Male; D018613:Microscopy, Confocal; D019704:Protein Disulfide-Isomerases / Q000096:biosynthesis*; D018013:Receptors, Neuropeptide / Q000096:biosynthesis*; D019139:Tumor Escape / Q000502:physiology*
D000091342:Endoplasmic Reticulum Chaperone BiP; C467732:GRP8 protein, human; C000717247:HSPA5 protein, human; D015395:Histocompatibility Antigens Class I; C099187:MHC class I-related chain A; D018013:Receptors, Neuropeptide; C496931:PDIA6 protein, human; D019704:Protein Disulfide-Isomerases